ArticleContemporary clinical trials communications2019
Towards detecting cocaine use using smartwatches in the NIDA clinical trials network: Design, rationale, and methodology.
Article in Contemporary clinical trials communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.
- A systematic review of remotely delivered contingency management treatment for substance use.Journal of substance use and addiction treatment · 2023Pooled it
- Using a Smartwatch App to Understand Young Adult Substance Use: Mixed Methods Feasibility Study.JMIR human factors · 2024Article
- Dynamic models of stress-smoking responses based on high-frequency sensor data.NPJ digital medicine · 2021Article
- The mobile assistance for regulating smoking (MARS) micro-randomized trial design protocol.Contemporary clinical trials · 2021Article
- The Validity of MotionSense HRV in Estimating Sedentary Behavior and Physical Activity under Free-Living and Simulated Activity Settings.Sensors (Basel, Switzerland) · 2021Article
- Using digital technologies in clinical trials: Current and future applications.Contemporary clinical trials · 2021Article
- Considerations for remote delivery of behavioral economic interventions for substance use disorder during COVID-19 and beyond.Journal of substance abuse treatment · 2021Article
- An Examination of the Feasibility of Detecting Cocaine Use Using Smartwatches.Frontiers in psychiatry · 2021Article
- Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff.Harm reduction journal · 2020Article
- Wearable and Wireless mHealth Technologies for Substance Use Disorder.Current addiction reports · 2020Article
- Digital Health and Addiction.Current opinion in systems biology · 2020Article
- The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network.Journal of substance abuse treatment · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 8 institutions in 1 country.
Funding
Abstract
Cocaine use in clinical trials is often measured via self-report, which can be inaccurate, or urine drug screens, which can be intrusive and burdensome. Devices that can automatically detect cocaine use and can be worn conveniently in daily life may provide several benefits. AutoSense is a wearable, physiological-monitoring suite that can detect cocaine use, but it may be limited as a method for monitoring cocaine use because it requires wearing a chestband with electrodes. This paper describes the design, rationale, and methodology of a project that seeks to build upon and extend previous work in the development of methods to detect cocaine use via wearable, unobtrusive mobile sensor technologies. To this end, a wrist-worn sensor suite (i.e., MotionSense HRV) will be developed and evaluated. Participants who use cocaine (N = 25) will be asked to wear MotionSense HRV and AutoSense for two weeks during waking hours. Drug use will be assessed via thrice-weekly urine drug screens and self-reports, and will be used to isolate periods of cocaine use that will be differentiated from other drug use. The present study will provide information on the feasibility and acceptability of using a wrist-worn device to detect cocaine use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.